1-112654579-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006135.3(CAPZA1):c.334G>A(p.Glu112Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000133 in 1,613,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
CAPZA1
NM_006135.3 missense
NM_006135.3 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 6.76
Genes affected
CAPZA1 (HGNC:1488): (capping actin protein of muscle Z-line subunit alpha 1) CAPZA1 is a member of the F-actin capping protein alpha subunit family. This gene encodes the alpha subunit of the barbed-end actin binding protein. The protein regulates growth of the actin filament by capping the barbed end of growing actin filaments. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007357806).
BS2
High AC in GnomAd4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPZA1 | NM_006135.3 | c.334G>A | p.Glu112Lys | missense_variant | 5/10 | ENST00000263168.4 | NP_006126.1 | |
CAPZA1 | XM_017002424.3 | c.334G>A | p.Glu112Lys | missense_variant | 5/10 | XP_016857913.1 | ||
CAPZA1 | XM_011542225.4 | c.334G>A | p.Glu112Lys | missense_variant | 5/9 | XP_011540527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPZA1 | ENST00000263168.4 | c.334G>A | p.Glu112Lys | missense_variant | 5/10 | 1 | NM_006135.3 | ENSP00000263168.3 | ||
CAPZA1 | ENST00000498626.1 | n.387G>A | non_coding_transcript_exon_variant | 6/9 | 5 | |||||
CAPZA1 | ENST00000476936.5 | n.182-4443G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000263 AC: 66AN: 250812Hom.: 0 AF XY: 0.000272 AC XY: 37AN XY: 135812
GnomAD3 exomes
AF:
AC:
66
AN:
250812
Hom.:
AF XY:
AC XY:
37
AN XY:
135812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000131 AC: 192AN: 1461626Hom.: 0 Cov.: 30 AF XY: 0.000132 AC XY: 96AN XY: 727136
GnomAD4 exome
AF:
AC:
192
AN:
1461626
Hom.:
Cov.:
30
AF XY:
AC XY:
96
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74346
GnomAD4 genome
AF:
AC:
23
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
21
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.334G>A (p.E112K) alteration is located in exon 5 (coding exon 5) of the CAPZA1 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the glutamic acid (E) at amino acid position 112 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at